Skip to main content
Volume 1  No 4 - Fall 2008

Volume 1 No 4 - Fall 2008

Table of Contents

Congenital Megaureter Images in Ob-Gyn
[Rev Obstet Gynecol. 2008;1(4):152-153]
Human Papillomavirus–Related Gynecologic Neoplasms: Screening and Prevention Update in Prevention
The recent recognition of oncogenic human papillomavirus (HPV) as a key component of female lower genital tract malignancies has led to significant changes in many screening and prevention guidelines for cervical cancer, and, combined with the advent of vaccination, will likely have sweeping repercussions on the incidence of cervical, vulvar, and vaginal carcinoma. This article focuses on the specific principles of cancer screening and prevention with an emphasis on HPV-mediated disease. [Rev Obstet Gynecol. 2008;1(4):154-161]
Omega-3 Fatty Acid Supplementation During Pregnancy Management Update
Omega-3 fatty acids are essential and can only be obtained from the diet. The requirements during pregnancy have not been established, but likely exceed that of a nonpregnant state. Omega-3 fatty acids are critical for fetal neurodevelopment and may be important for the timing of gestation and birth weight as well. Most pregnant women likely do not get enough omega-3 fatty acids because the major dietary source, seafood, is restricted to 2 servings a week. For pregnant women to obtain adequate omega-3 fatty acids, a variety of sources should be consumed: vegetable oils, 2 low-mercury fish servings a week, and supplements (fish oil or algae-based docosahexaenoic acid). [Rev Obstet Gynecol. 2008;1(4):162-169]
The Impact of Maternal Obesity on Maternal and Fetal Health Management Review
The increasing rate of maternal obesity provides a major challenge to obstetric practice. Maternal obesity can result in negative outcomes for both women and fetuses. The maternal risks during pregnancy include gestational diabetes and preeclampsia. The fetus is at risk for stillbirth and congenital anomalies. Obesity in pregnancy can also affect health later in life for both mother and child. For women, these risks include heart disease and hypertension. Children have a risk of future obesity and heart disease. Women and their offspring are at increased risk for diabetes. Obstetrician-gynecologists are well positioned to prevent and treat this epidemic. [Rev Obstet Gynecol. 2008;1(4):170-178]
Listeriosis in Pregnancy: Diagnosis, Treatment, and Prevention Management Review
Listeriosis is a rare disease that causes mild maternal illness, but can be devastating to the fetus. Listeria’s rare microbiologic features make it a difficult infection to diagnose and treat: it is an intracellular organism that hides within host cells. Because of the potentially severe consequences, it is important that obstetricians are familiar with the diagnosis, treatment, and prevention of listerial infection. [Rev Obstet Gynecol. 2008;1(4):179-185]
A Review of the Proceedings from the 2008 NICHD Workshop on Standardized Nomenclature for Cardiotocography Nomenclature
Despite evidence demonstrating no neonatal benefit, the medicolegal climate in the United States requires obstetricians to integrate continuous intrapartum surveillance into their care of the pregnant laboring patient. The intent of this article is to familiarize the reader with the most recent, standardized, quantitative nomenclature recommended to describe intrapartum CTG in order to reduce miscommunication among providers caring for the laboring patient, propagate consistent, evidence-based responses to CTG patterns, and systematize the terminology used by researchers investigating intrapartum CTG. [Rev Obstet Gynecol. 2008;1(4):186-192]
Obstetric Fistula: Living With Incontinence and Shame Women's Health in the Developing World
Over 2 million women worldwide have an obstetric fistula, with the majority of cases occurring in resource-poor countries. Afflicted women tend to be young, primiparous, impoverished, and have little or no access to medical care. Incontinent of urine and/or stool, these women become ostracized and shunned by their community. Most obstetric fistulas are surgically correctible, although surgical outcomes have been poorly studied. Programs that improve nutrition, delay the age of marriage, improve family planning, and increase access to maternal and obstetric care are necessary to prevent obstetric fistula. [Rev Obstet Gynecol. 2008;1(4):193-197]
Harmonic ACE™ Pistol Grip, Ethicon Endo-Surgery, Inc. Fall 2008 Product Reviews
[Rev Obstet Gynecol. 2008;1(4):198-199]
Bipolar Chip E-Vac System, Richard Wolf Fall 2008 Product Reviews
[Rev Obstet Gynecol. 2008;1(4):199-200]
Quill™ Self-Retaining System, Angiotech Pharmaceuticals, Inc. Fall 2008 Product Reviews
[Rev Obstet Gynecol. 2008;1(4):201-202]
Aging Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):203-204]
Hormone Replacement Terapy Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):205]
Cerebral Palsy Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):205-206]
Pelvic Organ Prolapse Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):206]
Preeclampsia Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):207]
Miscellaneous Reviewing the Literature
[Rev Obstet Gynecol. 2008;1(4):207-208]
Comment on “Why Epidurals Do Not Always Work” Letter to the Editors
[Rev Obstet Gynecol. 2008;1(4):209]